Efficacy and Safety of 14-Day Vonoprazan-Based Dual Therapy Versus Quadruple Therapy for Helicobacter Pylori Eradication: A Multicentre, Non-Inferiority Randomized Controlled Trial

Abroad (travel likely)Recruiting

Conditions

HELICOBACTER PYLORI INFECTIONS

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Qilu Hospital of Shandong University, Jinan, Shandong, China
Contact: Study coordinator (Yueyue Li) · lyynqj@126.com · 18560089751
Study coordinator · lyynqj@126.com
Qilu Hospital of Shandong University, Jinan, China
Contact: Study coordinator (Yueyue Li) · lyynqj@126.com · +8618560089751

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A "Screen and Treat" Helicobacter Pylori Eradication Trial in Adolescents in Three Regions of Chile

Helicobacter Pylori Infection

Abroad (travel likely)Recruiting

Coyhaique, Chile · Santiago, Chile

Head-to-head Study of Tegoprazan 50 mg BID Plus Amoxicillin 1 g TID vs. Vonoprazan 20 mg BID Plus Amoxicillin 1 g TID for H. Pylori Eradication

Helicobacter Pylori Infection

Abroad (travel likely)RecruitingPHASE2, PHASE3

Hangzhou, China

The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients

Acute Coronary Syndrome · Helicobacter Pylori Infection

Abroad (travel likely)RecruitingPHASE4

Bozhou, China · Chuzhou, China

A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring

Erosive Esophagitis · Heartburn · Symptomatic Non-erosive Gastroesophageal Reflux Disease

Abroad (travel likely)Recruiting

Wilmington, United States